NCT06919094 A Virtual Life Story Club Intervention to Improve Loneliness and Apathy in Community-Dwelling Older Adults
| NCT ID | NCT06919094 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Montefiore Medical Center |
| Condition | Apathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-08-15 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-08-15 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Reminiscence therapy is a non-invasive, non-pharmacological intervention that has been shown to improve cognition, mood, functional status, quality of life, and apathy in older adults. Group reminiscence therapy combines structured social engagement and recounting of personal stories that address both social connection (a risk factor for cognitive decline) and cognition. Life story club© (LSC) is an established, non-profit organization that provides virtual, group reminiscence therapy for older adults to reduce loneliness and promote a sense of belonging and has not been formally studied.
Eligibility Criteria
Inclusion Criteria: * Age 60 and over * English or Spanish fluency * Able to provide informed consent Exclusion Criteria: * Dementia based on Aging and Dementia (AD8) score of ≥4 or previous dementia diagnosis * Severe auditory or visual loss * Lack of access to internet connection or phone
Contact & Investigator
Mirnova Ceide, MD
PRINCIPAL INVESTIGATOR
Montefiore Medical Center
Frequently Asked Questions
Who can join the NCT06919094 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Apathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06919094 currently recruiting?
Yes, NCT06919094 is actively recruiting participants. Contact the research team at mceide@montefiore.org for enrollment information.
Where is the NCT06919094 trial being conducted?
This trial is being conducted at The Bronx, United States.
Who is sponsoring the NCT06919094 clinical trial?
NCT06919094 is sponsored by Montefiore Medical Center. The principal investigator is Mirnova Ceide, MD at Montefiore Medical Center. The trial plans to enroll 50 participants.